Literature DB >> 1004494

Interconversion phenomena between two kinetic forms of class a pyruvate kinase from Ehrlich ascites tumor cells.

J E Felíu, A Sols.   

Abstract

1. The regulatory properties of two interconvertible kinetic forms of class A pyruvate kinase from Ehrlich ascites tumor cells have been studied with a partially purified enzyme preparation free of interfering enzymatic activities. 2. The hyperbolic form shows Michaelis-Menten kinetics for P-pyruvate, with high affinity for this substrate and low affinity for the inhibitory amino acids alanine and phenylalanine. The sigmoidal form displays positive cooperativity respect to P-pyruvate (n=1.4), with lower affinity for this substrate and higher affinity for the inhibitory amino acids. 3. The equilibrium between the hyperbolic and the sigmoidal forms of the enzyme is affected by substraetes and effectors. P-pyruvate, ADP and Fru-P2 shift the equilibrium to the hyperbolic form while ATP, alanine and phenylalanine stabilize the sigmoidal form. 4. Effector metabolites affect the molecular weight of the protein, acting on an equilibrium between dimers and tetramers. P-pyruvate and ADP associate the enzyme to a tetramer while ATP, alanine and phenylalanine favor the occurrence as a dimer. The positive modifier Fru-P2 did not associate the enzyme to the tetramer, even at 1 mM concentration. 5. A tentative molecular model for pyruvate kinase A on the basis of the kinetic and aggregation interconversion is proposed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1004494     DOI: 10.1007/bf01732393

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

Review 1.  Enzymic phosphoryl group transfer.

Authors:  J F Morrison; E Heyde
Journal:  Annu Rev Biochem       Date:  1972       Impact factor: 23.643

2.  Multimolecular forms of pyruvate kinase. II. Purification of M 2 -type pyruvate kinase from Yoshida ascites hepatoma 130 cells and comparative studies on the enzymological and immunological properties of the three types of pyruvate kinases, L, M 1 , and M 2 .

Authors:  K Imamura; K Taniuchi; T Tanaka
Journal:  J Biochem       Date:  1972-10       Impact factor: 3.387

3.  Pyruvate kinase. Classes of regulatory isoenzymes in mammalian tissues.

Authors:  J Carbonell; J E Felíu; R Marco; A Sols
Journal:  Eur J Biochem       Date:  1973-08-01

4.  Distribution of pyruvate kinase isozymes among rat organs.

Authors:  K H Ibsen; E Krueger
Journal:  Arch Biochem Biophys       Date:  1973-08       Impact factor: 4.013

5.  Allosteric properties of a pyruvate kinase isoenzyme from rat liver cells in culture.

Authors:  P R Walker; V R Potter
Journal:  J Biol Chem       Date:  1973-07-10       Impact factor: 5.157

6.  Effects of L-alanine and fructose (1,6-diphosphate) on pyruvate kinase from ehrlich ascites tumour cells.

Authors:  G Sparmann; J Schulz; E Hofmann
Journal:  FEBS Lett       Date:  1973-11-01       Impact factor: 4.124

7.  Some distinctive properties of pyruvate kinase purified from rat liver.

Authors:  W A Susor; W J Rutter
Journal:  Biochem Biophys Res Commun       Date:  1968-01-11       Impact factor: 3.575

8.  Kinetic aspects of regulation of metabolic processes. The hysteretic enzyme concept.

Authors:  C Frieden
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

9.  Some kinetic properties of liver pyruvate kinase (type L). II. Effect of pH on its allosteric behavior.

Authors:  E Rozengurt; L Jiménez de Asúa; H Carminatti
Journal:  J Biol Chem       Date:  1969-06-25       Impact factor: 5.157

10.  Identification of two types of liver pyruvate kinase.

Authors:  B Hess; C Kutzbach
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1971-03
View more
  2 in total

1.  Age-related quantitative changes in enzyme activities of rat brain.

Authors:  J Vitorica; A Andrés; J Satrústegui; A Machado
Journal:  Neurochem Res       Date:  1981-02       Impact factor: 3.996

2.  Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation.

Authors:  Jamie A Macpherson; Alina Theisen; Laura Masino; Louise Fets; Paul C Driscoll; Vesela Encheva; Ambrosius P Snijders; Stephen R Martin; Jens Kleinjung; Perdita E Barran; Franca Fraternali; Dimitrios Anastasiou
Journal:  Elife       Date:  2019-07-02       Impact factor: 8.713

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.